Shattuck Labs

$38.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.41 (-5.95%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Shattuck Labs and other stocks, options, and ETFs commission-free!

About STTK

Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX. The listed name for STTK is Shattuck Labs, Inc. Common Stock.

CEO
Taylor H. Schreiber
Employees
—
Headquarters
Austin, Texas
Founded
2016
Market Cap
1.62B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
84.96K
High Today
$41.25
Low Today
$36.74
Open Price
$41.25
Volume
104.29K
52 Week High
$60.52
52 Week Low
$17.51

STTK Earnings

-$1.54
-$1.03
-$0.51
$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, After Hours

You May Also Like

RIO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure